HCA Healthcare, Inc. filed its Form 10-Q with the SEC on October 29, 2026, covering the quarterly period ended September 30, 2026, reporting consolidated revenues of $19,849 million for the third quarter and $59,188 million for the nine months ended September 30, 2026.

Key Highlights

  • Quarterly revenue: $19,849 million for the quarter ended September 30, 2026, compared to $19,161 million in the same quarter of 2025.
  • Nine-month revenue: $59,188 million for the nine months ended September 30, 2026, compared to $56,087 million in the prior-year period.
  • Net income attributable to HCA Healthcare: $1,579 million for Q3 2026, versus $1,643 million in Q3 2025; nine-month figure was $4,898 million versus $4,906 million.
  • Diluted earnings per share: $7.27 for the third quarter of 2026, compared to $6.96 in Q3 2025; nine-month diluted EPS was $22.05 versus $20.23.
  • Shares outstanding: 208,892,500 voting common shares outstanding as of October 26, 2026, down from 224,605,100 at December 31, 2025.
  • Long-term debt: $42,400 million as of September 30, 2026, compared to $41,603 million at December 31, 2025.
  • Cash dividends declared: $0.78 per share in Q1 2026, according to the stockholders' equity statement.

HCA Healthcare's Third-Quarter 2026 Financial Results: Revenues, Costs, and Capital Position

HCA Healthcare, Inc. (NYSE:HCA), the Nashville, Tennessee-based hospital and healthcare services operator, reported total revenues of $19,849 million for the quarter ended September 30, 2026, according to its condensed consolidated income statements included in the filing. This compares to $19,161 million reported for the same quarter in 2025. For the nine months ended September 30, 2026, the company disclosed revenues of $59,188 million versus $56,087 million in the comparable prior-year period. The company operates as a large accelerated filer and had 208,892,500 voting common shares outstanding as of October 26, 2026.

The filing disclosed that operating costs for the third quarter included salaries and benefits of $8,581 million, supplies of $2,822 million, and other operating expenses of $4,548 million. Depreciation and amortization for the quarter was $954 million, and interest expense was $607 million. Income before income taxes for Q3 2026 was $2,370 million, and the provision for income taxes was $521 million. Net income attributable to noncontrolling interests, which the company's hospital joint ventures generate, was $270 million for the quarter.

On the balance sheet as of September 30, 2026, the company reported total assets of $63,452 million, with goodwill and other intangible assets of $11,199 million and property and equipment net of accumulated depreciation of $32,268 million. Stockholders' deficit attributable to HCA Healthcare, Inc. stood at $(8,077) million, reflecting the company's ongoing share repurchase activity. The filing shows the company repurchased 3.157 million shares valued at $1,581 million in the first quarter of 2026 alone, contributing to the reduction in outstanding share count from 249.981 million shares at December 31, 2024 to 210,880,500 shares at the September 30, 2026 balance sheet date.

What Was Disclosed

HCA Healthcare filed its quarterly report covering the period ended September 30, 2026, disclosing revenues of $19,849 million for Q3 2026, diluted EPS of $7.27, total assets of $63,452 million, long-term debt of $42,400 million, and 208,892,500 common shares outstanding as of October 26, 2026.